top of page

BLOG &
NEWS
Search


Advanced Therapy Medicinal Products Don’t Fail for Scientific Reasons
**Advanced Therapy (ATMP) projects often fail from poor decision-making, not weak science. FRESCI tackles this bottleneck by structuring uncertainty, aligning evidence with strategic goals, and applying proactive regulatory science. Our focus: smarter decisions and clear thinking to navigate ATMP complexity and translate scientific potential into approved, accessible therapies.
FRESCI TEAM
Jan 163 min read


Bridging Science and Innovation in Organ-on-Chip and Organoids Development: 7 NEW YEARS TIPS
The Imperative of Market Viability/Economic sustainability In the rapidly evolving field of scientific research, particularly in...

Marco Straccia
Jan 8, 20243 min read


Navigating the INVISIBLE BARRIERS of Human Biology-Based Models in Health Research FUTURE Innovation
In the ever-evolving field of health research, there lies a complex interplay between technological standardization, market acceptance,...
FRESCI TEAM
Nov 21, 20233 min read


Our Biomedical Research Revolution: An EU AI-Powered Leap into Human Biology-Based Research
The biomedical research landscape is evolving at breakneck speed, ushering in an era of precision, accuracy, and human-centric...
FRESCI TEAM
Nov 15, 20233 min read


Are you a teacher?
We have a strong commitment with education and training, no matter the age! Early this year our CEO presented at The European School...
FRESCI TEAM
Dec 1, 20201 min read


Undervaluing brain immune system is most likely hampering the success of cell therapy...
Suggested reading!
FRESCI TEAM
Oct 13, 20201 min read
bottom of page